Perspective Therapeutics, Inc. (NYSE:CATX) Receives $15.14 Average Price Target from Brokerages
Shares of Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy […]
Shares of Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy […]
